ResearcherTUM KlinikumActive in the last 2 years
Max M. Schnurr
Matched on ORCID iD 0000-0001-6538-2474; OpenAlex author ID A5002385911. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2013: 1 paper · 2014: 4 papers · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 12
- RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jitc-2025-013282↗
- Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model. Co-author DOI 10.1007/s00262-020-02605-9↗
- Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. Co-author DOI 10.1186/s40425-019-0778-7↗
- Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. Co-author DOI 10.1186/s40425-019-0830-7↗
- Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer. Last author DOI 10.1016/j.canlet.2016.02.057↗
- Proapoptotic and antiapoptotic proteins of the Bcl-2 family regulate sensitivity of pancreatic cancer cells toward gemcitabine and T-cell-mediated cytotoxicity. Last author DOI 10.1097/cji.0000000000000073↗
- Strategies to relieve immunosuppression in pancreatic cancer. Co-author DOI 10.2217/imt.15.9↗
- RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8+ T cells Last author DOI 10.1038/cdd.2014.161↗
- RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells. Last author DOI 10.1038/cdd.2014.96↗
- P17. RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells Co-author DOI 10.1186/2051-1426-2-s2-p8↗
- Induction of immunogenic cell death by targeting RIG-I-like helicases in pancreatic cancer. Co-author DOI 10.4161/21624011.2014.955687↗
- Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer. Last author DOI 10.1158/0008-5472.can-11-3850↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Peter Duewell · 12 shared papers, 2013–2026 · strength 0.94
- Paper RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. DOI 10.1136/jitc-2025-013282↗
- Paper Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreat… DOI 10.1007/s00262-020-02605-9↗
- Paper Induction of immunogenic cell death by targeting RIG-I-like helicases in pancreatic cancer. DOI 10.4161/21624011.2014.955687↗
- Sebastian Kobold · 6 shared papers, 2014–2026 · strength 0.56
- Paper RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. DOI 10.1136/jitc-2025-013282↗
- Paper Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. DOI 10.1186/s40425-019-0778-7↗
- Paper Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreati… DOI 10.1186/s40425-019-0830-7↗
- Lars M. König · 4 shared papers, 2019–2026 · strength 0.52
- Paper RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. DOI 10.1136/jitc-2025-013282↗
- Paper Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreat… DOI 10.1007/s00262-020-02605-9↗
- Paper Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. DOI 10.1186/s40425-019-0778-7↗
- Philipp Metzger · 3 shared papers, 2019–2020 · strength 0.27
- Paper Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreat… DOI 10.1007/s00262-020-02605-9↗
- Paper Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. DOI 10.1186/s40425-019-0778-7↗
- Paper Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreati… DOI 10.1186/s40425-019-0830-7↗
- Anne Marie Senz · 1 shared paper, 2026 · strength 0.26
- Christian Alexander Bauer · 3 shared papers, 2015–2016 · strength 0.17
- Paper Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer. DOI 10.1016/j.canlet.2016.02.057↗
- Paper Strategies to relieve immunosuppression in pancreatic cancer. DOI 10.2217/imt.15.9↗
- Paper Proapoptotic and antiapoptotic proteins of the Bcl-2 family regulate sensitivity of pancreatic cancer cells toward gemc… DOI 10.1097/cji.0000000000000073↗
- Steffen Ormanns · 2 shared papers, 2016–2020 · strength 0.17
- Kirsten Lauber · 2 shared papers, 2015–2020 · strength 0.15
- Jens Thomas Siveke · 2 shared papers, 2014 · strength 0.08
- Paper RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD… DOI 10.1038/cdd.2014.161↗
- Paper RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD… DOI 10.1038/cdd.2014.96↗
- Thomas Mathias Gress · 1 shared paper, 2016 · strength 0.07
- Anna Trauzold · 1 shared paper, 2015 · strength 0.04
- Jonathan Ellermeier · 1 shared paper, 2013 · strength 0.03
- Gunther Hartmann · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.